Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on December 5, 2016, reporting events occurring between November 29, 2016, and December 5, 2016. The filing details the execution of a private placement of convertible senior notes to raise capital for working capital and general corporate purposes.
Key Financial Metrics
- Debt Issuance: $110.0 million aggregate principal amount of 2.00% Convertible Senior Notes due 2021.
- Option Exercise: Purchasers exercised an option to purchase an additional $15.0 million of Notes.
- Total Principal: $125.0 million.
- Net Proceeds: Approximately $120.7 million after deducting fees and estimated expenses.
- Interest Rate: 2.00% per annum, payable semiannually in arrears beginning June 1, 2017.
- Maturity Date: December 1, 2021.
- Conversion Terms: Initial conversion rate of 41.6082 shares per $1,000 principal amount (approx. $24.03 per share), representing a 27.50% premium over the November 29, 2016, closing price.
- Maximum Dilution: Initially convertible into 5,201,025 shares of Class A common stock.
Material Changes
The primary material change is the creation of a direct financial obligation through the issuance of the Notes. The Company loaned the net proceeds from the Private Placement to its subsidiary, Evolent Health LLC. This transaction increases the Company's debt load but provides significant liquidity for operations.
Outlook, Risks, and Contingencies
Management Commentary: Proceeds are intended for working capital and other general corporate purposes.
Risks and Contingencies:
- Conversion Risk: The Notes are convertible into Class A common stock, which may result in dilution to existing shareholders.
- Repurchase Obligation: Holders may require the Company to repurchase the Notes upon a "fundamental change" at 100.00% of the principal amount plus accrued interest.
- Interest Expense: The Company will incur semiannual interest payments starting in June 2017.
Investor Verification Checklist
- Verify the full text of the Indenture (Exhibit 4.1) for specific covenants and fundamental change definitions.
- Confirm the exact calculation of the conversion rate adjustments under various scenarios.
- Review the Purchase Agreement (Exhibit 10.1) for representations, warranties, and indemnification rights.
- Monitor the Company's cash flow to ensure ability to service the 2.00% interest payments and potential repurchase obligations.